Lucira Health, Inc.
Case Number:
1:23-bk-10242
Court:
Nature of Suit:
Firms
- Arnold & Porter
- Barnes & Thornburg
- Billion Law
- Brown Rudnick
- Bryan Cave
- Buchalter APC
- Connolly Gallagher
- Cooley LLP
- Cross & Simon
- Faegre Drinker
- Gellert Scali
- Landis Rath
- Lowenstein Sandler
- Monzack Mersky
- Morris James
- Potter Anderson
- Ralph Schwab & Schiever
- Richards Layton
- Rosner Law Group LLC
- Young Conaway
Companies
- Hain Capital Group LLC
- Jabil Inc.
- Lucira Health Inc.
- New England Biolabs Inc.
- Oracle Corp.
- Pfizer Inc.
- The Cigna Group
- United Parcel Service Inc.
Government Agencies
Sectors & Industries:
-
September 19, 2023
COVID Test Maker Lucira Gets OK For Ch. 11 Liquidation
COVID-19 testing company Lucira Health Inc. received approval Tuesday from a Delaware bankruptcy judge to liquidate its remaining assets in Chapter 11 after the company struck a $36.4 million deal in April to sell its business to Pfizer Inc.
-
April 04, 2023
Lucira Stock Sale Not Blocked By Ch. 11 Stay, Judge Says
A Delaware bankruptcy judge denied a request by COVID-19 testing firm Lucira Health Inc. to protect future tax credits by blocking a shareholder from selling its stock, saying Tuesday that the stay imposed by Lucira's Chapter 11 can't interfere with the shareholder's property rights.
-
February 24, 2023
COVID Testing Firm To Seek Ch. 11 Bids By Early April
Bankrupt COVID-19 testing firm Lucira Health Inc. made an initial appearance Friday in Delaware court, telling the court that it is seeking to complete a fast-paced sale process for its assets with bids due by early April.
-
February 22, 2023
COVID Test Maker Lucira Health Files For Ch. 11 Protection
COVID-19 test maker Lucira Health Inc. filed for Chapter 11 protection in Delaware federal bankruptcy court on Wednesday, listing its liabilities as between $50 million and $100 million and saying that it plans to sell its business amid lower demand for tests and slower-than-anticipated regulatory approval.